Palisade Bio, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for PALI, updated each market day.
PALI AI Sentiment
AI sees no strong directional signal for Palisade Bio, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Palisade Bio, Inc. Common Stock
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Sector
Exchange
Market Cap
$331,890,969
Cap Tier
Employees
14
Headquarters
CARLSBAD, CA
Listed Since
April 28, 2021
Website
PALI Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PALI Volatility
Palisade Bio, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
